Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 259.00 | 285.50 | 0.9072 | 0.8297 | |
| BT-20 | 17-AAG | 3.1623 | uM | 7 | 312.50 | 133.67 | 126.00 | 285.50 | 0.4413 | -0.0525 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 312.50 | 133.67 | 331.00 | 285.50 | 1.1594 | 1.2892 |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 312.50 | 133.67 | 334.00 | 285.50 | 1.1699 | 1.3082 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 312.50 | 133.67 | 316.00 | 285.50 | 1.1068 | 1.1943 |
| BT-20 | Lapatinib | 10 | uM | 7 | 312.50 | 133.67 | 95.00 | 285.50 | 0.3328 | -0.2679 |
| BT-20 | Linsitinib | 0.0033113 | uM | 7 | 312.50 | 133.67 | 428.00 | 285.50 | 1.4991 | 1.8949 |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 312.50 | 133.67 | 351.00 | 285.50 | 1.2294 | 1.4152 |
| BT-20 | Lapatinib | 1 | uM | 7 | 312.50 | 133.67 | 335.00 | 285.50 | 1.1734 | 1.3145 |
| BT-20 | Lapatinib | 0.31623 | uM | 7 | 312.50 | 133.67 | 330.00 | 285.50 | 1.1559 | 1.2829 |
| BT-20 | Erlotinib | 10 | uM | 7 | 312.50 | 133.67 | 305.00 | 285.50 | 1.0683 | 1.1244 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 312.50 | 133.67 | 193.00 | 285.50 | 0.6760 | 0.3987 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 312.50 | 133.67 | 296.00 | 285.50 | 1.0368 | 1.0671 |
| BT-20 | 17-AAG | 10 | uM | 7 | 312.50 | 133.67 | 115.00 | 285.50 | 0.4028 | -0.1284 |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 312.50 | 133.67 | 263.00 | 285.50 | 0.9212 | 0.8555 |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 314.00 | 285.50 | 1.0998 | 1.1816 | |
| BT-20 | Linsitinib | 10 | uM | 7 | 312.50 | 133.67 | 232.00 | 285.50 | 0.8126 | 0.6547 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 312.50 | 133.67 | 140.00 | 285.50 | 0.4904 | 0.0432 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 312.50 | 133.67 | 322.00 | 285.50 | 1.1278 | 1.2323 |
| BT-20 | 17-AAG | 0.0033113 | uM | 7 | 312.50 | 133.67 | 220.00 | 285.50 | 0.7706 | 0.5764 |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 261.00 | 285.50 | 0.9142 | 0.8426 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 286.00 | 285.50 | 1.0018 | 1.0032 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 3.00 | 285.50 | 0.0105 | -0.9688 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 2.00 | 285.50 | 0.0070 | -0.9785 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 259.00 | 285.50 | 0.9072 | 0.8297 |